Obstetric critical care

Peripartum cardiomyopathy

Reviewed Nov 2026·3 references
New· views rounded down, updated weekly

Diagnose PPCM by echo, treat heart failure with pregnancy-safe drugs, consider bromocriptine with anticoagulation, and escalate early to mechanical support in shock.

Definition
PPCM: heart failure with LVEF < 45% towards the end of pregnancy or in the months following delivery (mostly in the first month), with no other identifiable cause.

At the bedside

  1. 1

    Suspect and confirm

    Breathlessness, orthopnoea, oedema late pregnancy/postpartum: BNP/NT-proBNP, ECG, echocardiography; exclude pre-eclampsia, PE, AFE, myocarditis, pre-existing cardiomyopathy.

  2. 2

    Acute HF

    Oxygen/NIV, IV furosemide, nitrates if BP allows; avoid ACEi/ARB/ARNI/MRA/SGLT2i before delivery (use hydralazine-nitrate); beta-blocker (metoprolol) once stable.

  3. 3

    Cardiogenic shock

    Early transfer to a centre with MCS; levosimendan preferred inotrope (catecholamines, especially dobutamine, may be harmful in PPCM); IABP/Impella/VA-ECMO; urgent delivery if antepartum.

  4. 4

    Bromocriptine

    2.5 mg BD for 2 weeks then daily for 6 weeks (severe, EF < 25% or shock), always with anticoagulation; stops breastfeeding.

  5. 5

    Anticoagulation

    Therapeutic anticoagulation for LV thrombus, AF or EF < 30-35% (high thrombosis risk peripartum); at least prophylactic with bromocriptine.

  6. 6

    Postpartum

    Full guideline-directed HF therapy (ACEi/ARNI, MRA, beta-blocker, SGLT2i if not breastfeeding); counsel on future pregnancy risk.

PPCM (severe)

Bromocriptine

Oral
Dose
2.5 mg BD × 2 weeks, then 2.5 mg daily × 6 weeks

With anticoagulation.

Red flag · call your senior now
PPCM with hypotension, lactate rise or LVEF < 25%: high risk - transfer early for mechanical circulatory support.
Pitfall
Missing PPCM as 'postpartum anaemia' or 'chest infection'.
Pitfall
ACE inhibitors before delivery (fetotoxic).
Pearl
Enalapril and captopril are compatible with breastfeeding; ARNI and SGLT2 inhibitors are not recommended while breastfeeding.

Test yourself

Module quiz · score 70% to complete the module

Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.